- Home
- EHTH vs ESLA Comparison
EHTH vs ESLA Comparison
Compare EHTH & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EHTH | ESLA |
|---|---|---|
| Founded | 1997 | 2021 |
| Country | United States | United States |
| Employees | 1665 | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 32.0M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EHTH | ESLA |
|---|---|---|
| Price | $0.76 | $0.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.33 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 321.9K | 39.0K |
| Earning Date | 05-06-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $251,395,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.60 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 45.86 | N/A |
| 52 Week Low | $0.81 | $0.46 |
| 52 Week High | $5.89 | $3.15 |
Technical Indicators
Market Signals| Indicator | EHTH | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 24.69 | 23.83 |
| Support Level | N/A | N/A |
| Resistance Level | $1.58 | $0.85 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 1.97 | 2.68 |
Price Performance
Historical ComparisonAbout EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.